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Programmed cell death (PCD) or apoptosis is a gen-
etically regulated cell suicide process, central to the
control of cell proliferation and differentiation and to
the elimination of damaged and infected cells [1,2].
Conversely, viral subversion of PCD regulation plays
an important role in the dissemination and pathogene-
sis of several viral infections [3,4]. The human cytomeg-
alovirus (HCMV) causes severe disease in newborns
and immunocompromised hosts. In vivo, HCMV and
murine CMV induce apoptosis in various cell types
through different mechanisms that may favour either
viral clearance or disease development [5–8].
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Viral subversion of apoptosis regulation plays an important role in the
outcome of host ⁄ virus interactions. Although human cytomegalovirus
(HCMV) encodes several immediate early (IE) antiapoptotic proteins (IE1,
IE2, vMIA and vICA), no proapoptotic HCMV protein has yet been iden-
tiﬁed. Here we show that US28, a functional IE HCMV-encoded chemo-
kine receptor, which may be involved in both viral dissemination and
immune evasion, constitutively induces apoptosis in several cell types. In
contrast, none of nine human cellular chemokine receptors, belonging to
three different subfamilies, induced any signiﬁcant level of apoptosis.
US28-induced cell death involves caspase 10 and caspase 8 activation, but
does not depend on the engagement of cell-surface death receptors of the
tumour necrosis factor receptor ⁄CD95 family. US28 cell-death induction is
prevented by coexpression of C-FLIP, a protein that inhibits Fas-asso-
ciated death domain protein (FADD)-mediated activation of caspase 10
and caspase 8, and by coexpression of the HCMV antiapoptotic protein
IE1. The use of US28 mutants indicated that the DRY sequence of its
third transmenbrane domain, required for constitutive G-protein signalling,
and the US28 intracellular terminal domain required for constitutive US28
endocytosis, are each partially required for cell-death induction. Thus, in
HCMV-infected cells, US28 may function either as a chemokine receptor, a
phospholipase C activator, or a proapoptotic factor, depending on expres-
sion levels of HCMV and ⁄or cellular antiapoptotic proteins.
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HCMV encodes several immediate early (IE) pro-
teins, with antiapoptotic properties, namely IE1, IE2,
vMIA and vICA [9–11]. IE1 and IE2 each inhibit
apoptosis induced by tumour necrosis factor (TNF)a
or by E1B-19 kDa protein-deﬁcient adenovirus, and
IE2, but not IE1, protects smooth muscular cells
(SMC) from p53-mediated apoptosis [12]. vMIA
blocks apoptosis at the mitochondria level without
sharing structural homology with Bcl-2 protein family
members. vICA inhibits Fas-mediated apoptosis by
binding to the pro-domain of caspase 8 and preventing
its activation. Despite the presence of several antiapop-
totic proteins encoded by CMV, no HCMV gene prod-
uct that causes apoptosis induction has been identiﬁed.
HCMV contains four open reading frames US27,
US28, UL33 and UL78 that encode G-protein-coupled
receptors (GPCR) [13]. US28, one of the earliest viral
genes transcribed in both latently and productively
HCMV-infected cells, is a functional CC chemokine
receptor that can promote different functions in vitro
[14,15]. US28 allows CMV-infected SMC migration,
which could provide a molecular mechanism for
CMV’s implication in the progression of vascular dis-
ease [16]. US28 withdraws CC chemokines from the
infected cell microenvironment [17], suggesting a
potential involvement in immune evasion, and enhan-
ces cellular fusion induced by different viral envelopes,
suggesting that it could participate in cell-to-cell diffu-
sion of CMV and other viruses [18]. US28 acts also as
a coreceptor for HIV [18–21].
It has been shown that US28 induces phospho-
lipase C (PLC) and NF-jB activation constitutively,
independent of the binding of any ligand [22,23]. US28
can also undergo rapid receptor endocytosis and recyc-
ling in a ligand-independent fashion. The US28 C-ter-
minal domain is constitutively phosphorylated by
GRK family proteins, then b-arrestin recruitment
attenuates constitutive signalling and allows constitu-
tive receptor endocytosis and recycling via a clathrin-
mediated mechanism [23–25].
Here we show that US28 constitutively induces
apoptosis in different cell types by triggering activa-
tion of initiator caspase 8 and caspase 10, independ-
ent of cellular TNF family death receptor activation,
via a pathway that appears partially dependent on
the integrity of the third US28 transmembrane
domain (TM) required for constitutive PLC activation
and on the presence of the US28 intracellular C-ter-
minal domain required for its internalization. Thus,
depending on its expression level and on the expres-
sion level of HCMV-encoded or cellular antiapoptotic
proteins, US28 may provide HCMV-infected cells
with a broad functional repertoire, by acting either as
a chemokine receptor, a PLC activator, or as a pro-
apoptotic protein.
Results
US28 expression induces apoptosis
Adherent human 293T cells were transiently transfected
with an HCMV expression vector encoding either the
HCMV CC chemokine receptor US28 from the labor-
atory strain AD169, or the human CC chemo-
kine receptor CCR-5. As a negative control, we used
an empty vector (Rc ⁄CMV). As a positive control for
apoptosis induction, cells were transfected with a vec-
tor encoding human Bax, a major proapoptotic mem-
ber of the Bcl-2 ⁄Bax protein family, which acts
downstream of cell-surface signalling by inducing
outer membrane permeabilization of mitochondria
[26]. We assessed cell death using both optical micros-
copy analysis of cell adherence loss (Fig. 1A) and
ﬂow cytometry analysis of nuclear DNA loss (hypo-
diploidy) (Fig. 1B), a typical feature of apoptosis.
Both Bax and US28 expression induced cell death
within 48 h, whereas transfection of CCR-5 or the
empty vector Rc ⁄CMV did not affect cell survival
(Fig. 1A,B). Using ﬂow cytometry analysis of hypo-
diploidy, we then performed a comparative kinetic
analysis of cell death following expression of US28,
Bax, the human chemokine receptors CCR-5 and
CXCR-4, or the aminopeptidase CD26, which has no
chemokine receptor activity (Fig. 1C). Bax expression
led to rapid induction of apoptosis that was already
signiﬁcant 18 h after transfection and resulted in
>50% cell death by 72 h (Fig. 1C). US28 expression
induced a slower kinetics of cell death that was signi-
ﬁcant at 48 h, resulting in >35% cell death by 72 h
(Fig. 1C). In contrast, neither CCR-5, CXCR-4,
CD26, nor the empty vector Rc ⁄CMV induced any
signiﬁcant apoptosis during 72 h after transfection. At
48 h post-transfection, we compared the effect of
US28 expression on cell death induction versus that
of nine other human chemokine receptors represent-
ing three different receptor subfamilies: CCR-1, -3, -4
and -5, CXCR-1, -2, -4 and -6, and CX3CR-1.
Human chemokine receptors induced either no, or
only moderate, apoptosis (Fig. 1D), suggesting that
the capacity of US28 to trigger cell death was some-
how unique among chemokine receptors. Although
we did not analyse the expression levels for all the
different chemokine receptors, these constructs have
been extensively used in other studies from our labor-
atories and showed receptor expression and function-
ality [14,18,27] (personal communication). We also
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analysed cell death induced by US28 ampliﬁed from
two other HCMV strains, the clinical isolate
VHL ⁄E and the laboratory isolate Toledo (Fig. 2A).
Seventy-two hours after transfection, US28–VHL ⁄E
induced cell death at a level comparable with that
of US28–AD169 ( 30%), whereas US28 from the
laboratory isolate Toledo induced higher levels of
cell death ( 45%) (Fig. 2A). Expression levels of
US28 in ﬁbroblasts infected with different HCMV
isolates (AD169, Toledo and TB40 ⁄E) do not show
signiﬁcant differences [28] and, most importantly,
are even higher ( 1 · 106 sites per cell) than
expression levels obtained with transient transfection
( 2 · 105 sites per cell). Hence, cell death induction
by US28, expressed at even higher levels in HCMV-
infected cells, appears to be a general property of
HCMV.
Cellular localization and expression level of US28
It has been shown previously that epitope-tagged ver-
sions of the US28 receptor and US28–GFP fusion pro-
tein do not modify the cellular localization of the
native receptor [24]. We used N-terminally tagged
US28 and CCR-5 to compare their cell-surface expres-
sion levels, and US28–GFP and CCR-5–GFP to com-
pare their whole cellular expression levels and
localization. Concerning cell-death induction, tagged
chemokine receptors and GFP-fused receptors behaved
like native ones (Table 1). Flow cytometry analysis
using a tag-speciﬁc antibody for tagged chemokine
receptors, indicated that 16 h after transfection, before
the onset of US28-induced cell death, US28 and CCR-
5 were expressed at similar levels:  25% of the whole
cell population expressed the receptors at the surface
Fig. 1. Induction of apoptosis by US28 expression. Subconfluent 293T cells were transfected using the calcium phosphate precipitate
method with vectors expressing either the HCMV chemokine receptors US28, various cellular chemokine receptors, the proapoptotic Bax
protein as a positive control for apoptosis induction, and the aminopeptidase CD26 or the empty Rc ⁄CMV vector as negative controls (Con-
trol). Cell death was assessed 48 h after transfection by (A) light microscopy (·150), and (B) flow cytometry analysis of DNA loss (PI stain-
ing) in adherent cells (numbers indicate the percentage of hypodiploid cells). (C) Kinetics of apoptosis (DNA loss) following transfection with
Bax, US28, CD26, or the cellular chemokine receptors CCR-5 and CXCR-4. (D) Apoptosis (DNA loss) induced 48 h after transfection by Bax,
US28, CD26, and nine different cellular chemokine receptors (CCR-1, -3, -4, -5, CXCR-1, -2, -4, -6 and CX3CR-1). Results are means ± SD of
one representative experiment of two (C) or three (D).
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(Table 1 and data not shown). This implies that differ-
ences in cell-death induction did not result from differ-
ences in cell-surface expression. However, ﬂow
cytometry analysis 16 h post transfection of GFP-fused
receptors reveals that the overall cellular level of US28
expression is greater than that of CCR-5 (52.8 versus
35.1), suggesting that US28 is expressed mostly in the
intracellular compartment, as previously described
[24,25]. Using US28 and US28–GFP, we then explored
the effect of different amounts of transfected DNA on
both US28 whole-cell expression and cell-death induc-
tion levels in 293T cells. Transfection of 2 lg of each
vector induced 30–35% of cell death after 72 h, and
US28–GFP expression (% of GFP + cells) appeared
to be  60% (Fig. 2B.C). Comparaison of PCD
induced by US28–GFP and CCR-5–GFP when trans-
fected cells express similar level of GFP indicates that
a high expression level of US28, compared with that
of CCR-5, was not directly responsible for US28-medi-
ated cell-death induction.
Apoptosis appeared only in US28–GFP expressing
cells, which represented >50% of the whole GFP +
population (Fig. S1). This suggests that US28 does not
trigger cell death by a diffusable factor, because survi-
val of untransfected cells is not affected by neighbour-
ing US28-expressing cells. Nuclei were stained with
Hoescht 24 and 48 h post transfection of 293T cells.
After 24 h no apoptotic nuclei were detected (Fig. S2).
After 48 h, some US28–GFP+, but not CCR-5–
GFP+, cells showed shrinkage with apoptotic nuclei.
This could be partially inhibited in presence of the pan
caspase inhibitor z-VAD-fmk (Fig. S2).
US28 induces cell death in different cell types
Because US28–GFP induced cell death only in the
US28–GFP+ cells, we investigated US28–GFP-medi-
ated cell death in different cell lines using ﬂow cyto-
metry analysis of hypodiploidy in the GFP+ cell
population. US28–GFP expression 72 h post transfec-
tion, was 70.88, 22.8 and 6.60% in 293T, HeLa and
Cos cells, respectively, and cell death appeared,
respectively, in 40.87, 64.34 and 42.44% of US28–
GFP+ cells (Table 2). In each case the pan caspase




Fig. 2. Effects of US28 from different CMV isolates on cell death,
and effects of different expression levels of US28 on cell death. (A)
Subconfluent 293T were transfected using the calcium phosphate
method by expression vectors of US28–AD169, US28–VHL ⁄ E and
US28–Toledo. Flow cytometry analysis of DNA loss (PI staining)
(numbers indicate the percentage of hypodiploid cells) was per-
formed 72 h post transfection. (B) Transfection as in (A) of different
amounts (from 0 to 2 lg for 4 wells of 24-well plates) of expression
vector of US28. Cell were detached 72 h later, and anlysed for
DNA loss (PI staining). (C) Transfection as in (A) of different
amounts (from 0 to 2 lg for 4 wells of 24-well plates) of expression
vector US28–GFP, and as control, of 2 lg of CCR-5–GFP vector.
Cell were detached 72 h later, and analysed using flow cytometry
for DNA loss (PI staining), and GFP expression. Results are means
± SD of triplicates in two independent experiments (A–C).
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US28-induced apoptosis is repressed by protein
kinase inhibitors
Signal transduction following ligand binding to CC
chemokine receptors, including US28, involves activa-
tion of Pertussis toxin (PTX)-sensitive Gai proteins [7,
41]. PTX had no proapoptotic activity on mock trans-
fected cells, and no inhibitory effect on cell death
induced by US28 expression in the absence of any
added CC chemokine (or on Bax-induced death, used
as a control) (Fig. 3A). Addition of the US28 ligands,
CC chemokine RANTES or the CX3C chemokine
fractalkine (50 nm), did not modify US28-induced
apoptosis (data not shown). This suggests that US28-
mediated death signalling is not a default pathway
triggered in the absence of ligand. A protein tyrosine
kinase (PTK) pathway has been shown to be necessary
for SMC migration induced by US28, which, LIKE
cell death, is not sensitive to PTX [16]. The tyrosine
PTK inhibitor, Genistein, and the phosphoinositol
3-kinase inhibitor, LY 294002, reduced US28 cell
death (Fig. 3A), suggesting that the US28 cell-death
pathway uses various kinase families, some of which
may be necessary for US28-induced SMC migration.
US28-induced apoptosis is repressed by the
HCMV immediate early protein IE1, and depends
on caspase 10 and caspase 8 activation
Execution of PCD involves two pathways that usually
operate together and amplify each other [32, 38]. One is
triggered by the activation of initiator caspases, such as
caspase 10 and caspase 8, downstream of the engage-
ment of cell-surface death receptors of the CD95 ⁄
tumour necrosis factor receptor (TNFR) family, lead-
ing to the recruitment of the adapter protein FADD,
and subsequently to caspase-dependent death [29]. The
other, triggered by various proapoptotic stimuli, inclu-
ding p53 activation, requires a mitochondria-dependent
step, under the control of antiapoptotic and proapop-
totic members of the Bcl-2 ⁄Bax protein family, which
can induce either caspase-dependent or caspase-inde-
pendent death [26]. Bax represents an example of a
proapoptotic protein that induces mitochondria-
dependent, caspase-independent PCD [30]. To further
Table 1. Comparative analysis of cell-surface expression or whole-
cell expression, and cell-death induction, by epitope-tagged US28












Rc ⁄CMV-Tag 5.5 20.0 ± 1.0
Tag-US28 24.3 115.0 ± 0.8
Tag-CCR-5 28.8 21.6 ± 2.1
Rc ⁄CMV 0.6 12.9 ± 8.1
GFP 73.4 7.2 ± 0.9
US28–GFP 52.8 114.2 ± 11.6
CCR-5–GFP 35.1 24 ± 5.8
a 293T cells were transfected with US28, CCR-5 or the empty
Rc ⁄CMV vector, each carrying an N-terminal myc tag, or with GPF,
US28–GFP, CCR-5–GFP, or the empty Rc ⁄CMV vector. b Flow
cytometry analysis of cell-surface expression was performed 16 h
after transfection using a monoclonal antibody specific for the myc
tag. Results are from one representative experiment. c Flow cyto-
metry analysis of the whole cell expression was performed 16 h
after transfection. Results are from one representative experiment.
d Flow cytometry analysis of apoptosis (nuclear DNA loss) was
assessed 48 h after transfection using PI staining. Results in are
means ± SD of at least two independent experiments.
Table 2. Cell death induction using US28–GFP in 293T, Cos-7 and HeLa cells.
Cellsa Vectors
Whole populationb Cells death in GFP + populationc
% of cell death % of GFP + cells – + Z-VAD
293T GFP 2.15 ± 0.26 99.54 ± 0.11 2.16 ± 0.26 –
CCR5-GFP 7.22 ± 1.76 42.34 ± 6.00 17.05 ± 3.67 –
US28-GFP 34.26 ± 3.48 70.83 ± 4.51 48.51 ± 5.78 24.76 ± 3.8
HeLa CCR5-GFP – 10.00 ± 1.66 9.00 ± 1.40 –
US28-GFP – 22.88 ± 7.48 64.34 ± 12.23 28.49 ± 6.5
Cos-7 CCR5-GFP – 4.51 ± 0.40 11.60 ± 2.40 –
US28-GFP – 6.60 ± 1.21 42.44 ± 14.38 11.76 ± 4.6
a Cells were transfected using the calcium phosphate method. Per cent GFP + cells obtained with the empty Rc ⁄CMV vector:
1.87 ± 2.39% for 293T cells, 2.13 ± 0.40% for HeLa cells, and 2.59 ± 0.86% for Cos-7 cells. b Flow cytometry analysis of whole-cell GFP
expression and of cell death induction was assessed 72 h after transfection. Results are from a representative experiment. c Analysis for
red (x-axis) and green (y-axis) fluorescence allows to determine the percentage of GFP + apoptotic cells. The pan caspases-inhibitor z-VAD-
fmk was used at the concentration of 50 lM.
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explore the pathway involved in US28-mediated cell
death, we examined the effect of coexpressing various
proteins with US28: Bcl-XL, an antiapoptotic member
of the Bcl-2 family that prevents mitochondria-depend-
ent death, p35, a baculovirus-encoded pan-caspase
inhibitor [31] and two different HCMV-encoded anti-
apoptotic proteins, IE1 and IE2 that have been repor-
ted to prevent TNFR-mediated apoptosis [11]. IE2, but
not IE1, also prevents p53-mediated death [12]. As con-
trols, we examined the effect of coexpressing these
proteins on Bax-induced death.
Bcl-XL expression almost completely prevented Bax-
induced cell death, as previously described [26], but
had no effect on US28-induced cell death (Fig. 3B).
p35, as expected, had little effect on Bax-mediated cell
death, but reduced US28-mediated death. Neither IE1
nor IE2 showed any effect on Bax-mediated cell death,
while IE1, but not IE2, reduced US28-mediated cell
death (Fig. 3B). These results suggest that US28, in
contrast to Bax, may induce a caspase-dependent,
mitochondria-independent death pathway, which can
be blocked either by HCMV-IE1 expression or by
caspase inhibitors.
To further explore the potential role of caspase acti-
vation in US28-mediated death signalling, we used the
pan-caspase inhibitory peptide, z-VAD-fmk. US28-
induced cell death was inhibited in a dose-dependent
manner by z-VAD-fmk (Fig. 4A). Flow cytometry
analysis using tagged US28 indicated that this inhibi-
tory effect was not due to downregulation of US28
surface expression (data not shown). This was further
conﬁrmed by investigating the effect of z-VAD-fmk
on the capacity of US28, like that of CCR-5, to func-
tion as a coreceptor for R5-tropic HIV1 strains [18–
21]. Using a cell-fusion assay, involving cocultures of
control, US28- or CCR-5-expressing HeLa P4 reporter
cells and HIV1 ADA envelope-expressing HeLa cells,
we found that z-VAD-fmk induced a 100% increase
in the ability of US28 to function as an HIV corecep-
tor, while reducing by  30% that of CCR-5
(Fig. 4B). Although we found that the level of US28
surface expression was similar to that of CCR-5
(Table 1), US28–HIV coreceptor function has been
reported to be less than half as efﬁcient as that of
CCR-5 in HeLa P4 cells [18,19]. In the presence of a
pan-caspase inhibitor, US28 was a more efﬁcient core-
ceptor for HIV than CCR-5 (Fig. 4B), suggesting that
the HIV coreceptor activity of US28 may have been
underestimated previously because of its proapoptotic
activity [18–21].
We further explored the caspase activation pathway
triggered by US28 expression using selective caspase
inhibitory peptides. Inhibitors of death receptor-
coupled initiator caspases 10 and 8 and inhibitors of
downstream executionary caspases 3 and 6 showed
inhibitory effects similar to that of z-VAD-fmk
(Fig. 4C). In contrast, inhibition of caspase 9, the initi-
ator caspase activated downstream of mitochondria
permeabilization, or inhibition of caspase 1, a pro-
inﬂammatory caspase, had no effect on US28-induced
cell death (Fig. 4C). A comparative kinetic study of
the time window in which caspase 10 and 8 inhibitors
prevent cell death following US28 expression indicated
that the inhibitory effect of the caspase 10 inhibitor
was lost several hours before that of the caspase 8
inhibitor (Fig. 4D). This suggests that caspase 10 acti-
vation may either occur upstream of caspase 8 activa-
Fig. 3. Inhibition of US28-induced apoptosis. (A) 293T cells were
transfected with vectors expressing Bax or US28. PTX, an inhibitor
of Gai protein subunits, LY294002, an inhibitor of phosphatidylinosi-
tol 3-kinase, and Genistein a inhibitor of tyrosine protein kinases
were added 4 h after transfection. All compounds were used at
maximal nontoxic concentrations as determined in preliminary
experiments. (B) 293T cells were cotransfected with either Bax or
US28, and either Bcl-XL, which protects against Bax-induced apop-
tosis, P35, a baculovirus-encoded pan-caspase inhibitor, or the
HCMV encoded immediate early proteins IE1, or IE2. Percentages
of inhibition of apoptosis were assessed as described in Experi-
mental procedures. Results are means ± SD from one of three rep-
resentative experiments.
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tion in response to US28 expression, or be more effect-
ive in inducing death. We assessed caspase 3 and 8
activities 24 h post transfection, by caspase 3-mediated
cleavage of z-MCA-VDQMDGWK(DNP)-NH2, and
caspase 8-mediated cleavage of z-IETD-AFC, over a
time course of 90 min (Fig. S3). Caspase 3 and 8 activ-
ities were signiﬁcantly higher in US28-expressing cells
than in controls (Rc ⁄CMV) (Fig. S3), whereas 16 h
after transfection both activities were weak and similar
in US28-expressing cells and controls (data not
shown). Taken together, these data imply that US28
triggers a death pathway that depends on activation of
initiator caspases 10 and 8, leading rapidly to execu-
tionary caspase activity without requiring a mitochon-
dria-dependent step.
US28 cell-death induction is prevented by
C-FLIP expression, but not by death receptor
neutralization
Activation of caspases 10 and 8 downstream of death
signalling by cell-surface receptors of the TNFR family
occurs through recruitment of these caspases to death
effector domains (DED) containing adapter proteins
[29,32,33]. This process is inhibited by cellular mem-
bers of the FLIP family and their viral homologues
[34]. We established HeLa cells stably expressing cellu-
lar C-FLIP to explore the effect of C-FLIP on US28–
GFP cell-death induction. As shown in both Table 2
and Fig. 5A, expression of US28 in wild-type HeLa
cells induced 3 days after US28 transfection, cell death
Fig. 4. Inhibition of US28-induced apoptosis by caspase inhibitors. (A) Apoptosis was assessed in 293T cells 48 h after US28 transfection, in
the presence of various concentrations of the pan-caspase inhibitor, z-VAD-fmk. (B) HeLa P4 cells, stably expressing CD4, were transfected
by the calcium phosphate method with US28, CCR-5 or empty (Control) vectors and cocultured with HeLaEnv ⁄ADA cells, stably expressing
HIV envelope, in the presence or absence of z-VAD-fmk. Syncytia formation is an indicator of HIV-coreceptor activity and receptor surface
expression. (C) Apoptosis was assessed in 293T cells 48 h after US28 transfection in the presence or absence, of either the pan-caspase
inhibitor z-VAD-fmk, or of various selective caspase inhibitors. (D) Kinetic analysis of the inhibitory effect of caspase 8 and caspase 10 inhibi-
tors on apoptosis induced by US28 transfection in 293T cells. Percentages of inhibition of apoptosis in (A, C, D), and numbers of syncytia in
(B) were determined as described in Experimental procedures. Results are means ± SD from one representative experiment out of three (A)
or two (B–D).
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in  60% of US28–GFP+ HeLa cells (Fig. 5A). In
contrast, in HeLa–C-FLIP cells, US28 expression
induced death in only  35% cells (Fig. 5A), indicating
that C-FLIP reduces US28-induced cell death. US28-
induced cell death also appeared strongly reduced in
the breast cancer cell line MCF-7 (Fig. 5A), defective
in the expression of the apoptosis effector caspase 3
[35], which is necessary for US28-mediated apoptosis.
The death receptor family is composed of different
death ligand ⁄ receptor pairs of the TNF ⁄TNFR family,
such as CD95 (Fas) ⁄CD95L, TNF ⁄TNFR1, TNF ⁄
TNFR2, TRAIL ⁄TRAILR1 and TRAIL ⁄TRAILR2
[29]. Decoy receptors have previously been shown to
block the interaction between these ligands and their
receptors, and ligand-mediated cell death. Treatment
of US28-tranfected 293T cells with the decoy receptors
CD95-Fc, which neutralizes CD95L, TNFR1-Fc,
which neutralizes TNF, or TRAILR2-Fc, which neut-
ralizes TRAIL, did not prevent cell death observed
3 days after US28 transfection (Fig. 5B). These data
suggest that US28 triggers a cell-death pathway that
can be blocked by C-FLIP expression, but which is
independent of the engagement of members of the
TNF receptor family by their ligands.
Role of constitutive activity and the C-terminal
cytoplasmic domain of US28 in induction of
apoptosis
Previously, we have shown that US28 constitutively
activates several intracellular pathways, resulting in an
increase in inositol phosphate (InsP) accumulation as
well as NF-jB-driven transcription [22]. Our results
indicated that these effects are mediated via US28 coup-
ling to G proteins of the q ⁄ 11 family [22]. Interestingly,
several studies have demonstrated that enhancement of
Gq activity can lead to apoptosis induction via the acti-
vation of a protein kinase C (PKC)-dependent pathway
[36–38]. To investigate whether the activation of this sig-
nalling route plays a role in US28-mediated cell death,
we tested the apoptotic effect induced by a signalling
deﬁcient mutant, referred to as US28–R129A. US28–
R129A carries a mutation in the DRY sequence at the
bottom of TM-3, a motif that is highly conserved in
class A G-protein-coupled receptors (GPCRs) and plays
a pivotal role in G-protein activation [39].
US28–R129A appears unable to induce InsP turn-
over in HEK293T cells (see Fig. 6A in comparison to
US28-wild type), although its level of expression at the
cell surface is similar to US28–WT, as determined by
125I-labelled-CX3CL1 ⁄ fractalkine binding (Fig. 6B).
Interestingly, US28–R129A-induced apoptosis was sig-
niﬁcantly reduced (Fig. 6C) indicating that activation
of Gq ⁄ 11 proteins is involved in US28-mediated cell
death. However, the residual apoptotic effect of US28–
R129A clearly denotes that additional pathways play a
role in the effects observed with US28–WT.
*
Fig. 5. US28 cell death is inhibited by C-FLIP expression and does
not involve members of the TNFR family. (A) Subconfluent HeLa
cells, or C-FLIP stably expressing HeLa cells, or as control MCF-7
cells, were transfected using the calcium phosphate method with
vectors expressing, US28–GFP or the control vector Rc ⁄CMV vec-
tor. Cell were detached 72 h later, and analysed for red PI staining
(DNA loss), and GFP fluorescence. Results are the percentage of
apoptotic US28–GFP+ cells. (B) Subconfluent 293T cells were
transfected by the calcium phosphate method with vectors expres-
sing, US28–GFP or the control vector Rc ⁄CMV vector, in presence
or absence of decoy receptors (30 lgÆmL)1) that block receptor–
ligand interactions. Shown are the percentages of US28-dying cells
as assessed by PI straining. *Difference between US28 cell death
induction in HeLa and HeLa–C-FLIP cells are statistically significant
(t-test, P < 0.001). Triplicate samples were run at each time point
and data represent means ± SD of two independent experiments
(A), and of one representative experiment of two (B).
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Previous studies have shown that the US28 receptor
undergoes constitutive endocytosis and recycling at the
cell surface [24]. This phenomenon depends on con-
stitutive phosphorylation of serines in the C-terminus
of US28 by GRKs and consequent recruitment of
b-arrestin-2 to the plasma membrane [23,40]. We have
previously shown that deletion of the C-terminal of
US28 generates a receptor (US28-D300) which is
unable to constitutively internalize and is fully locali-
zed at the cell membrane [25]. As can be seen in
Fig. 6A, US28-D300 constitutively couples to Gaq ⁄ 11
proteins, similarly to WT receptor, indicating that con-
stitutive activity and internalization proﬁles are distinct
properties of US28. Consistent with the idea that this
receptor mutant does not undergo constitutive inter-
nalization, its expression levels at the cell surface are
signiﬁcantly higher than US28-WT (Fig. 6B). The
apoptotic effect induced by US28-D300 is reduced in
comparison with WT (Fig. 6C), especially if consider-
ing that the receptor mutant has higher expression
levels. These results indicate that the C tail of US28,
responsible for receptor internalization proﬁles, is also
involved in cell-death induction.
Discussion
To our knowledge, our ﬁndings provide the ﬁrst identi-
ﬁcation of a virally encoded chemokine receptor which
constitutively induces cell death. Apoptosis triggered
by the HCMV CC chemokine receptor US28 depends
on caspase activation and appears independent of both
the mitochondria-dependent death pathway and the
engagement by their ligands of death receptors of the
TNFR family. US28-induced cell death appears unique
among chemokine receptors, because nine human
chemokine receptors belonging to three different sub-
families do not induce signiﬁcant constitutive death.
Although engagement of the human chemokine recep-
tor CXCR-4 by its chemokine (SDF-1) and ⁄or viral
ligand (HIV envelope) has been reported to induce
apoptosis in some cell types, no constitutive death
induction by a chemokine receptor in the absence of
ligand has yet been identiﬁed.
Our results were obtained in cells transfected with
US28, a system that allowed us to analyse the beha-
viour of different US28 mutants and compare it with
other human chemokine receptors. A critique often
made to this type of studies is that receptor expression
levels are often not physiological in transfected cells.
However, this is not the case for US28, because infec-
tion of permissive cells with HCMV results in even
higher levels of US28 than in our study [28], due to
the strength of CMV promoters for early genes.
In vitro, survival of HCMV-infected cells may result
from neutralization of US28-induced cell death by the
different HCMV antiapoptotic proteins (IE1, IE2,
vMIA, vICA). However, cell death induced by US28
could be responsible of CMV apoptosis observed
in vivo in various cells.
Our ﬁnding that US28 constitutively induces apop-
tosis might explain our inability to obtain stable US28
expression in a variety of cell lines, including the Chi-
nese hamster ovarian (CHO) cell line, four human
myeloid cell lines (THP1, U937, HL60 and K562), the
HEK293T cell line, and one human glioma cell line
permissive for CMV infection (U373-MG) (unpub-
lished results). We also observed that the only HeLa
clone, which we previously obtained and reported as
stably expressing US28 [19], could not be maintained
for long periods in culture, while we easily obtained
















































Fig. 6. Cell-death induction by the US28 mutants R129A and D300. (A) InsP accumulation induced by US28, US28–R129A and US28–D300,
was evaluated in 293T cells, as described in Experimental procedures. (B) Surface expression of the different US28 mutants was monitored
in HEK 293T cells by binding of 125I-labelled fractalkine ⁄CX3CL1. Data are normalized as binding sites per cell. (C) Cell-death induction by
US28, US28–R129A or US28–D300, was evaluated 72 h post transfection in 293T cells as in Fig. 1B. Results are means ± SD of three inde-
pendent experiments.
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and maintained stable CCR-3 or CCR-5 transfectants
(data not shown). However, we were able to stably
express US28 in the murine NIH 3T3 and SVEC
cells, suggesting that the cell-death-inducing activity
of US28 is strongly dependent on the cellular
environment. Two different US28 stably expressing
HEK293 cell lines and one US28 stably expressing
K562 cell line have been described by others [41,42].
After obtaining one US28-expressing HEK293 cell line
[41], we found it behaved like our previously reported
HeLa clone, namely we could not maintain it in cul-
ture (data not shown).
Our ﬁndings using US28 mutants suggest that both
US28 constitutive signalling through Gq ⁄ 11 proteins
and US28 receptor internalization play a role in apop-
tosis induction. Results suggest that the two signalling
pathways are independent and additive. Interestingly,
the involvement of such pathways in apoptosis has
been previously reported in other models of cell-death
induction. Indeed, several studies have demonstrated
that enhancement of Gq activity induces apoptosis of
cultured cells and cardiac myocytes in transgenic mice
[36,37]. Moreover, transfection of a constitutively act-
ive mutant of Gaq into COS-7 and CHO cells was
found to induce apoptosis through a PKC-dependent
pathway [38]. Also, increasing evidence indicates that
GPCRs can modulate several intracellular signals
through mechanisms that are independent from G-pro-
tein activation. In particular, GPCR interaction with
arrestin proteins is actively involved in signal transduc-
tion, in particular activation of the nonreceptor tyro-
sine kinase SRC and mitogen-activated protein kinase
[43,44].
Our ﬁndings indicate that apoptosis induced by
US28 expression can be repressed by concomitant
expression of either the antiapoptotic HCMV-encoded
immediate early protein IE1, the cellular protein
C-FLIP, or by the use of synthetic caspase inhibitors.
Interestingly, both IE1, and FLIP proteins prevent
apoptosis induction by ligand-mediated engagement of
two cell-surface death receptors, TNFR and CD95 that
trigger death via recruitment of DED-containing adap-
ter proteins which lead to recruitment and activation
of caspase 10 and ⁄or caspase 8. C-FLIP represses such
death signalling through direct interference with adap-
ter protein-mediated recruitment and activation of
caspase 10 and 8. To investigate the possible involve-
ment of TNF family ligand and death receptors in
US28 cell death, we used soluble recombinant CD95,
TNFR2 and TRAIL extracellular domains fused to
the immunoglobulin Fc domain, which inhibit apopto-
sis induced by CD95L, TNF and TRAIL, respectively,
by acting as soluble decoy receptors. All these decoy
receptors failed to protect cells from US28-induced cell
death, suggesting that US28-induced cell death does
not depend on such death receptor engagement by
their ligands. Caspase-mediated cell death induction
independent of TNFR family death receptors has also
been reported in a process called Anoikis, which is a
caspase-dependent apoptosis induced by loss of inte-
grin-mediated adhesion to extracellular matrix in the
absence of any other death-inducing stimuli [45].
Our ﬁnding that US28-induced apoptosis is preven-
ted by IE1 expression suggests that HCMV might
function, at least partially, according to the adenovirus
paradigm of viral-mediated regulation of cell survival
and cell death. Expression of an adenovirus gene prod-
uct required for viral replication, e.g. E1A, induces
cell death thereby aborting infection unless addi-
tional antiapoptotic viral gene products, e.g. E1B, are
expressed that allow infected cell survival [46]. Accord-
ingly, US28, one of the earliest HCMV gene products
expressed in both latently and productively infected
cells [47,48], might lead to apoptosis as a default path-
way, unless IE1 is also expressed, allowing repression
of cell-death induction. In contrast to the adenovirus
E1A protein, however, the HCMV US28 protein does
not appear to be required for the HCMV cycle, at
least in vitro [17].
In vivo, the function of US28 as a chemokine recep-
tor has been proposed to provide HCMV with several
potential advantages, including viral dissemination
through RANTES-mediated chemotaxis of infected
cells [16], immune evasion via the clearance of proin-
ﬂammatory chemokines from the environment of infec-
ted cells [17], and possibly activation of the infected
cell for its latency or replication by constitutive PLC
signalling [41]. Our ﬁnding that US28 can induce con-
stitutive death implies that repression of apoptosis
induction might be a prerequisite for its function as a
chemokine receptor or cellular activator, and also rai-
ses the question of the potential role that US28-medi-
ated death induction may play in HCMV ⁄host
interactions. US28-induced apoptosis of infected cells
could contribute to viral dissemination, once active
viral replication has been achieved, but also to the
immune control of systemic infection by stimulating
antiviral CD8 T-cell responses through ingestion of
these apoptotic cells by dendritic cells [49].
All b and most of c herpesviruses encode chemokine
receptor homologues [15]. Our ﬁnding that one of
them, US28, is involved in constitutive death induc-
tion, raises the question of whether this represents an
exception or rather a particular example of a general
strategy of viral subversion of chemokine receptor
functions. It should be noted that proof of the concept
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of constitutive receptor-mediated cell-death induction
is difﬁcult to obtain, because extreme ligand promiscu-
ity may be an alternative mechanism allowing viral
chemokine receptors to signal in the presence of as yet
unknown chemokines. Whatever the mechanism(s)
involved, the virally encoded chemokine receptor US28
might provide infected cells with unique functional
properties, which differ from those conferred by their
human cellular homologues.
Finally, viral chemokine receptor death signalling
might represent an opportunity for therapy. Indeed,
our ﬁnding that the expression of IE1 can repress
US28-induced apoptosis could enhance interest in cur-




The pan-caspase inhibitor z-VAD-fmk was purchased from
Bachem (Voisins-le-Bretonneux, France). The selective caspase
inhibitors, z-WEHD-fmk (caspase 1), z-DEVD-fmk (caspase
3), z-VEID-fmk (caspase 6), z-IEYD-fmk (caspase 8),
z-LEHD-fmk (caspase 9) and z-AEVD-fmk (caspase 10), and
chemokines RANTES and Fractalkine were from R&D
Laboratories (Abingdon, UK). Pertussis toxin was purchased
from Sigma Chemical Co. (St. Louis, MO), Genistein from
Alexis Corp (San Diego, CA), and LY-294002 from Calbio-
chem (La Jolla, CA). Human CD95-Fc immunoglobulin
fusion protein, which binds CD95L, TRAILR2-Fc, which
binds TRAIL, and TNFR1-Fc, which binds TNFa and
lymphotoxin a, were provided by P. Schneider.
Cells
All cell lines were grown in Dulbecco’s modiﬁed Eagle’s
medium containing 10% decomplemented fetal bovine
serum and antibiotics (60 mgÆmL)1 penicillin and
100 mgÆmL)1 streptomycin). HeLa-tat-Env ⁄ADA cells sta-
bly express HIV R5-tropic ADA strain envelope protein,
and HeLa P4 cells stably express CD4 and long-terminal
repeat (LTR)-LacZ. P4 cells were cultured in the presence
of G418 neomycin, and HeLa-tat-Env ⁄ADA cells in pres-
ence of methotrexate.
Expression vectors
Expression vectors of US28–ad169, US28–VHL ⁄E, US28–
Toledo, and cellular chemokine receptors have been des-
cribed elsewhere [14,18,27,51]. Bax, Bcl-XL, and p35
expression plasmids were obtained by cloning the cDNAs
into pcDNA3. Bax and Bcl-XL cDNAs were provided by
S. Korsmeyer (Departments of Pathology and Medicine,
Harvard Medical School, Boston, MA) and p35 cDNA by
J. Abrams (Departments of Pharmacology and Biochemis-
try, University of Texas South-Western Medical, Dallas,
TX). Expression vectors for CMV IE1 and IE2 were
obtained from R. LaFemina (Department of Antiviral
Research, Merck Research Laboratories, West Point, PA).
C-FLIP expression vector was obtained by J. Tschopp
(Department of Biochemistry, University of Lausanne,
Epalinges, Switzerland) [52].
US28 mutants, US28–GFP and CCR-5–GFP fusion
proteins
US28–WT and US28–R129A from CMV–AD169 strain
and US28–R129A subcloned in pcDEF3 have been previ-
ously described [53]. The C-terminus truncation mutant
US28-D300 was generated by PCR according to previous
literature [25] and subcloned in pcDEF3 vector. Enhanced
green ﬂuorescent protein (EGFP) fusion constructs were
created using the pEGFP-N1 vector (Clontech Laborator-
ies, Palo Alto, CA) by ligation of PCR fragments ampliﬁed
from US28 and CCR-5 between XhoI and HindIII sites.
Detection of tagged chemokine receptors and
EGFP
For ﬂow cytometry analysis of myc-tagged receptors, 293T
cells were analysed 16 h after transfection with tagged
chemokine receptor vectors after cell detachment with phos-
phate-buffered saline (NaCl ⁄Pi) containing 1 mm EDTA.
Cells (105) were pelleted and incubated for 1 h at 4C
with Cy3-conjugated anti-Myc IgG, 9E10 (Sigma) at
0.5–2 lgÆmL)1 in NaCl ⁄Pi +1% bovine serum albumin
(washing buffer). After washing, cells were analysed using a
FACScan ﬂow cytometer (Becton Dickinson, Mountain
View, CA).
Measurement of apoptosis
293T cells were seeded in 24-well plates (2 · 104 cells per
well), incubated overnight at 37 C in complete medium,
then transfected by the calcium phosphate technique
(0.5 lg of plasmid DNA per well, or 0.3 lg of each plasmid
DNA per well in cotransfection experiment). Adherent cells
were recovered at indicated time points post transfection by
incubation in NaCl ⁄Pi containing 1 mm EDTA, and
washed in NaCl ⁄Pi. DNA content loss (hypodiploidy) was
assessed by ﬂow cytometry analysis of propidium iodide
(PI) (2 lgÆmL)1) (Sigma) staining in the presence of 1%
saponin, using a FACScan ﬂow cytometer (Becton Dickin-
son). Caspase inhibitors or other inhibitory molecules were
added to cells 4 h after transfection. Because expression
vectors were under the control of the CMV enhancer ⁄ pro-
moter, the effect of inhibitors on this enhancer ⁄ promoter
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was veriﬁed in parallel using cells transfected with a con-
trol CMV vector expressing LacZ (pCMV-LacZ) and
b-galactosidase activity was assessed as previously des-
cribed [54]. None of the inhibitors affected b-galactosidase
expression.
In others cell lines, cell-death induction was monitored
after transfection of US28–GFP or CCR-5–GFP fusion
proteins, or GFP alone, 3 days after transfection in 24-well
plates by determining the amount of DNA loss (hypodi-
ploidy) in GFP+ cells by ﬂow cytometry analysis.
HIV-Env syncytia formation assay
Brieﬂy, HeLa P4 cells (105 cells per well), stably transfected
with CD4 and a lacZ gene under the control of the HIV-
LTR, were seeded in six-well plates and transfected with 3 lg
of DNA per well using the calcium phosphate technique.
Syncytia formation was assessed 48 h after transfection using
HeLa-Tat-Env-ADA cells, as previously described [18,19].
b-Galactosidase activity, generated upon syncytia formation,
was quantiﬁed as described previously [54].
Insositol phosphate accumulation
293T cells were plated in 24-well plates in Dulbecco’s modi-
ﬁed Eagle’s medium supplemented with 10% fetal bovine
serum and transfected by the calcium phosphate method.
Eight hours after transfection, the medium was replaced
with inositol-free Dulbecco’s modiﬁed Eagle’s medium sup-
plemented with 10% dialysed fetal bovine serum and myo-
[2-3H]inositol (3 lCiÆmL)1). After overnight incubation, the
labelling medium was aspirated, cells were washed for
10 min with Dulbecco’s modiﬁed Eagle’s medium contain-
ing 25 mm Hepes (pH 7.4) and 20 mm LiCl, then incubated
for 1 h in the same medium. Incubation was stopped by
aspiration of the medium and addition of cold 10 mm for-
mic acid. After 90 min incubation on ice, InsP were isolated
by anion exchange chromatography (Dowex AG1-X8 col-
umns, Bio-Rad) and measured by liquid scintillation.
Binding experiments
Labelling of fractalkine ⁄CX3CL1 (residues 1–72; Peprotech,
Rocky Hill, USA) with 125I using the IODOGEN method
(Pierce, Rockford, IL) was performed as described previously
[55]. Two days after transfection, HEK293T cells were incu-
bated with 0.6 nm 125I-labelled fractalkine in binding buffer
(50 mm Hepes pH 7.4, 1 mm CaCl2, 5 mm MgCl2 and 0.5%
bovine serum albumin) for 3 h at 4 C. After incubation,
cells were washed four times at 4 C with binding buffer sup-
plemented with 0.5 m NaCl. Nonspeciﬁc binding was deter-
mined in the presence of 0.1 lm cold chemokine. Data were
analysed with the program graphpad prism (San Diego,
CA).
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Supplementary material
The following material is available online:
Fig. S1. Detection of GFP-fused chemokine receptors
and cell-death induction. Subconﬂuent 293T cells were
transfected by the calcium phosphate method with vec-
tors expressing (A) the control Rc ⁄CMV vector, (B)
the GFP, and (C) CCR-5–GFP or (D) US28–GFP
fusion proteins. Cells were detached 72 h later, and
analysed using ﬂow cytometry for DNA loss (PI stain-
ing) (x-axis), and green GFP ﬂuorescence (y-axis). The
percentages of living GFP + cells are indicated on the
right and the percentages of apoptotic GFP + cells on
the left.
Fig. S2. Fluorescent microscope analysis of GFP and
GFP-fused chemokine receptors US28 and CCR-5.
Cells were examined 48 h post transfection after strain-
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ing with HOESCHT 33342, in the presence or in
absence of z-VAD-fmk in US28–GFP transfected cells.
The arrow indicates typical nuclear chromatin conden-
sation and fragmentation in dying cells.
Fig. S3. Caspase 3 and 8 activation by US28. Caspase
3 and 8 activation is expressed as raw ﬂuorescence
units as a result of z-MCA-VDQMDGWK(DNP)-
NH2 and z-IETD-AFC hydrolysis, respectively. 293T
cells (2 · 106) were transfected with 10 lg of US28
expression vector or the empty vector Rc ⁄CMV as a
control. Transfected cells were incubated 24 h later
with each substrate at 25 C for 0 min (immediately
following mixing) and 90 min later. No signiﬁcative
difference was obtained at time 0. Duplicate samples
were run at each time point and data represent means
± SD of two experiments.
FEBS Journal 272 (2005) 4163–4177 ª 2005 FEBS 4177
O. Pleskoff et al. HCMV chemokine receptor US28 induces apoptosis
